Saccharomyces cerevisiae engineering bacteria for producing mogroside as well as construction method and application thereof
By constructing the Saccharomyces cerevisiae engineering bacteria, knocking out the EXG1 gene and expressing the glycosyltransferases UGTMG1 and UGT98, the efficient biosynthesis of rosy glycosides was achieved, and the problems of rosy glycoside production efficiency and purity in the existing technology were solved, achieving high yield goal.
Patent Information
- Application Number
- CN202411120592.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-15
- Publication Date
- 2024-11-22
AI Technical Summary
The prior art is difficult to achieve large-scale production of high-yield and high-purity rosin glycosides, and the microbial chassis has catalytic activity and stability problems in the biosynthesis of rosin glycosides.
By constructing the S. cerevisiae engineered bacteria, knocking out the endogenous EXG1 gene, screening and expressing the glycosyltransferases UGTMG1 and UGT98, the whole-cell catalytic synthesis of the cerevisiae is achieved, and the yield of the cerevisiae in S. cerevisiae is increased.
The efficient biosynthesis of rohan cerevisiae was successfully achieved in Saccharomyces cerevisiae, especially the yield of rohan cerevisiae V reached 1842.67ng/mL, solving the catalytic activity and stability of microbial chassis in rohan cerevisiae synthesis.
Smart Images

Figure CN118995457A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of bioengineering, and in particular relates to an engineering bacterium of brewer's yeast for producing mogroside, and a construction method and application thereof. Background Art
[0002] As a natural sweetener, mogroside has a variety of biological activities that are beneficial to humans, including lowering blood pressure, lowering blood lipids, protecting the liver, inhibiting bacteria and inflammation, anti-oxidation, and enhancing the body's immunity. However, the current production of mogroside compounds relies heavily on plant extraction, making it difficult to achieve large-scale production of high-yield and high-purity mogroside. With the advancement of metabolic engineering and the emergence of emerging synthetic biology tools, it has become possible to sustainably produce mogroside using microbial chassis. In the field of industrial microbiology, Saccharomyces cerevisiae has been widely used. As a cell factory, it has shown many advantages, including stability, safety, and the availability of sufficient terpenoid precursors. Therefore, it is expected to become an efficient chassis cell for heterologous biosynthesis of mogroside. Summary of the invention
[0003] In order to solve the problems existing in the prior art, the present invention provides an engineered yeast of Saccharomyces cerevisiae for producing mogroside, a construction method and application thereof.
[0004] The first object of the present invention is to provide an engineered yeast of Saccharomyces cerevisiae for producing mogroside, to increase the expression levels of glycosyltransferases UGTMG1 and UGT98 in an exg1 deletion strain of Saccharomyces cerevisiae, or to increase the expression levels of glycosyltransferases UGTMG1 and UGTMS1_M7 in an exg1 deletion strain of Saccharomyces cerevisiae.
[0005] Preferably, the Saccharomyces cerevisiae exg1 deletion strain is obtained by knocking out the EXG1 gene in Saccharomyces cerevisiae using the gRNA-tRNAarray CRISPR method.
[0006] Preferably, the nucleotide sequence of UGTMG1 is SEQ ID No. 1 in the sequence list; and / or
[0007] The nucleotide sequence of UGT98 is SEQ ID No. 10 in the sequence list; and / or
[0008] The nucleotide sequence of UGTMS1_M7 is SEQ ID No. 8 in the sequence list.
[0009] The second object of the present invention is to provide a method for constructing the above-mentioned engineering bacteria of Saccharomyces cerevisiae for producing mogroside, comprising the following steps:
[0010] (1) UGTMG1 was constructed into the yeast expression vector pRS414 to obtain plasmid pRS414-MG1;
[0011] UGT98 or UGTMS1_M7 was constructed into the yeast expression vector pRS425 to obtain plasmid pRS425-98 or pRS425-MS1_M7;
[0012] (2) transforming the plasmid pRS414-MG1 obtained in step (1) into the exg1 deletion strain of Saccharomyces cerevisiae to obtain strain S-UGTMG1;
[0013] (3) The plasmid pRS425-98 or pRS425-MS1_M7 obtained in step (1) is transformed into the strain S-UGTMG1 to obtain the engineered yeast Saccharomyces cerevisiae S-UGT98 or S-UGTMS1_M7 that produces mogroside.
[0014] The third object of the present invention is to provide a method for constructing the above-mentioned engineering bacteria of Saccharomyces cerevisiae for producing mogroside, comprising the following steps:
[0015] (1) Both UGTMG1 and UGT98 genes were constructed into the vector pRS425 to obtain plasmid pRS425-98-MG1;
[0016] (2) The plasmid pRS425-98-MG1 was transformed into the exg1 deletion strain of Saccharomyces cerevisiae to obtain the engineered strain S1 of Saccharomyces cerevisiae that produces mogroside.
[0017] The fourth object of the present invention is to provide the use of the above-mentioned engineered yeast Saccharomyces cerevisiae in the production of mogroside.
[0018] Preferably, the mogroside includes at least one of mogroside III, simanoside I, mogroside IV-A, mogroside IV-E and mogroside V; preferably, the mogroside is mogroside V.
[0019] Preferably, the above-mentioned engineered yeast Saccharomyces cerevisiae is cultured, and mogrosanthes alcohol is added to carry out in vitro transformation of the yeast. After the transformation is completed, methanol is added to stop the reaction.
[0020] The fifth object of the present invention is to provide a method for producing mogroside, characterized in that: the above-mentioned brewer's yeast engineering bacteria are cultivated, mogroside alcohol is added to carry out yeast in vitro transformation, and after the transformation is completed, methanol is added to stop the reaction.
[0021] Preferably, the mogroside includes at least one of mogroside III, simanoside I, mogroside IV-A, mogroside IV-E and mogroside V; preferably, the mogroside is mogroside V.
[0022] The present invention, by taking advantage of the natural advantages of Saccharomyces cerevisiae, first determined that the 1,3-β-glucan exoenase encoded by its endogenous EXG1 gene has the activity of degrading the β-1,6-glucosidic bond of mogroside. EXG1 was knocked out to obtain the chassis cell Δexg1 that cannot degrade the β-1,6-glucosidic bond of mogroside. Subsequently, the glycosyltransferase was screened, and the glycosyltransferase UGTMG1 with strong primary glycosylation ability and the glycosyltransferase UGT98 with strong secondary glycosylation ability were found. Using Δexg1 as the chassis strain, the synthesis of the target product, mogroside V, was achieved by the whole-cell catalysis method, wherein the yield of mogroside V of the constructed strain S1 reached 1842.67 ng / mL, thereby achieving the heterologous synthesis of mogroside V by Saccharomyces cerevisiae. BRIEF DESCRIPTION OF THE DRAWINGS
[0023] The accompanying drawings are used to provide a further understanding of the present invention and constitute a part of the specification. Together with the embodiments of the present invention, they are used to explain the present invention and do not constitute a limitation of the present invention. In the accompanying drawings:
[0024] Figure 1 Shown are the growth curves of CEN.PK2-1D and Δexg1 strains.
[0025] Figure 2 To evaluate the degradation ability of CEN.PK2-1D and Δexg1 strains on mogroside IA / IE / IIE.
[0026] Figure 3 This is an evaluation of the degradation ability of CEN.PK2-1D and Δexg1 strains on mogroside III / IIIE.
[0027] Figure 4 This is an evaluation of the degradation ability of CEN.PK2-1D and Δexg1 strains on simanoside I / mogroside IV-A / IV-E.
[0028] Figure 5 Evaluation of the degradation ability of CEN.PK2-1D and Δexg1 strains on mogroside V.
[0029] Figure 6 This is a schematic diagram of the degradation ability of Exg1 on mogroside.
[0030] Figure 7 Schematic diagram of the biosynthesis pathway of mogroside in monk fruit. SQE, squalene epoxidase; CDS, cucurbitadienol synthase; EPH, epoxide hydrolase. The hydroxyl group on C-11 introduced by CYP87D18 is highlighted in orange. The glucose moieties bound by UGT720-269-1 and UGT94-289-3 are highlighted in green and blue, respectively.
[0031] Figure 8 This is the LC-MS test result of the crude enzyme extract of strain S-UGTMG1.
[0032] Fig. 9 This is the LC-MS test result of the crude enzyme extract of strain S-UGT269.1.
[0033] Fig.10 This is the LC-MS detection result of the crude enzyme extract of strain S-UGT269.1 (-23aa).
[0034] Fig.11 This is the LC-MS test result of the crude enzyme extract of strain S-UGT430.
[0035] Fig.12 This is the LC-MS test result of the crude enzyme extract of strain S-UGT1576.
[0036] Fig.13 This is the LC-MS test result of the crude enzyme extract of strain S-UGT1697.
[0037] Fig.14 This is the LC-MS test result of the crude enzyme extract of strain S-UGTMS1.
[0038] Fig.15 This is the LC-MS test result of the crude enzyme extract of strain S-UGTMS1_M7.
[0039] Fig.16 This is the LC-MS test result of the crude enzyme extract of strain S-UGTMS2.
[0040] Fig.17 This is the LC-MS test result of the crude enzyme extract of strain S-UGT98.
[0041] Fig.18 This is the LC-MS test result of the crude enzyme extract of strain S-UGT11789.
[0042] Fig.19 It is the in vitro enzymatic activity of UGTs.
[0043] In each figure, * represents isomers.
[0044] Fig. 20 The whole cell catalyzes the production of mogroside by glycoside hydrolase for primary glycosylation.
[0045] Fig.21 LC-MS detection results of mogroside IE (MIE) were generated for strains S-UGTMG1, S-UGT269.1(-23aa) and S-UGT430.
[0046] Fig. 22 LC-MS detection results of mogroside IIE (MⅡE) were generated for strains S-UGTMG1, S-UGT269.1(-23aa) and S-UGT430.
[0047] Fig.23 The whole cell catalyzes the production of mogroside by glycoside hydrolase for secondary glycosylation.
[0048] Fig.24 LC-MS detection results of mogroside III (MⅢ) were generated for strains S-UGTMS1, S-UGTMS1_M7, S-UGTMS2, S-UGT98 and S-UGT11789.
[0049] Fig.25 LC-MS detection results of mogroside IV-A (MIV-A), siamenoside Ⅰ (SiaⅠ) and mogroside IV-E (MIV-E) were generated for strains S-UGTMS1, S-UGTMS1_M7, S-UGTMS2, S-UGT98 and S-UGT11789.
[0050] Fig.26 LC-MS detection results of mogroside V (MV) were generated for strains S-UGTMS1, S-UGTMS1_M7, S-UGTMS2, S-UGT98 and S-UGT11789.
[0051] Fig. 27 LC-MS detection results of mogroside III (MⅢ) produced by strains S1, S2, S3, and S4.
[0052] Fig.28 LC-MS detection results of mogroside IV-A (MIV-A) produced by strains S1, S2, S3, and S4.
[0053] Fig.29 LC-MS detection results of mogroside V (MV) produced by strains S1, S2, S3, and S4.
[0054] Fig.30 The yield of mogroside produced by strains S1, S2, S3 and S4. DETAILED DESCRIPTION
[0055] The following examples are provided for a better understanding of the present invention, but are not intended to limit the present invention. The experimental methods in the following examples are conventional methods unless otherwise specified. The experimental materials used in the following examples are purchased from conventional biochemical reagent companies unless otherwise specified. The quantitative tests in the following examples are repeated three times, and the results are averaged.
[0056] Example 1 Knockout of the endogenous EXG1 gene encoding glycoside hydrolase in Saccharomyces cerevisiae
[0057] Mogroside is a glycosylated product synthesized by mogroside alcohol under the catalysis of glycosyltransferase. The glucose branch chains at the C3 and C24 positions of mogroside alcohol are glycosylated to different degrees to synthesize different types of mogrosides, including mogroside IA, mogroside IE, mogroside ⅡE, mogroside Ⅲ, mogroside ⅢE, simenoside Ⅰ, mogroside Ⅳ-A, mogroside Ⅳ-E and mogroside Ⅴ. Among them, the types of glycosylation modification are all β-glycosidic bonds, including β-D-glucosidic bonds, β-(1,6)-D-glucosidic bonds and β-(1,2)-D-glucosidic bonds. In 2013, Chiu et al. found that the 1,3-β-glucan exoenase encoded by the endogenous EXG1 gene in yeast has β-glycoside hydrolase activity and can degrade mogroside V. The above is a qualitative study on the degradation of mogrosides by Exg1, but there is a lack of quantitative research on the degradation effects of Exg1 on different types of mogrosides, as well as the degradation effects of Exg1 on different types of β-glycosidic bonds.
[0058] To address the above issues, we first knocked out the endogenous EXG1 gene of Saccharomyces cerevisiae, studied the degradation effect of Exg1 on different types of mogrosides from a quantitative detection perspective, and constructed yeast cells that cannot degrade mogrosides.
[0059] 1 Materials and methods
[0060] 1.1 Strains, plasmids and primers
[0061] The starting strain used in the study was Saccharomyces cerevisiae CEN.PK2-1D, which was used for gene expression and pathway construction. The constructed yeast strains are shown in Table 1; Escherichia coli (E. coli stable) was used for plasmid amplification, and the constructed plasmids are shown in Table 2; the primers used in the construction of plasmids are shown in Table 3. The primers used in the construction of plasmids and strains were synthesized by Beijing Qingke Biotechnology Co., Ltd.
[0062] Table 1 Saccharomyces cerevisiae strains used in the experiments
[0063]
[0064] Table 2 Plasmids used in the experiment
[0065]
[0066] Reference 1: Li S, Si T, Wang M, Zhao H. Development of a synthetic malonyl-CoAsensor in Saccharomyces cerevisiae for intracellularmetabolite monitoring and genetic screening. ACS Synth Biol. 2015; 4:1308-15. Reference 2: ZHANG Y, WANG J, WANG Z, et al. A gRNA-tRNA array for CRISPR-Cas9 based rapid multiplexed genome editing in Saccharomyces cerevisiae[J].Nature Communications, 2019,10(1).
[0067] Table 3 Primers used in the experiment
[0068]
[0069] 1.2 Plasmid construction
[0070] The construction process of the plasmid used in the present invention:
[0071] (1) DNA amplification: Use high-fidelity DNA polymerase 2×Phanta Flash Master Mix to amplify gene fragments for plasmid construction and gene integration. DNA polymerase is used for PCR verification. The general reaction system and reaction procedure are shown in Tables 4 and 5. Set the annealing temperature according to the Tm value of the primer, and set the extension time according to the length of the desired target fragment.
[0072] Table 4 PCR reaction system
[0073] Components volume 2×MasterMix 25μL Upstream primer (10 μM) 1μL Downstream primer (10 μM) 1μL Template DNA (200ng) xμL <![CDATA[ddH2O]]> upto50μL
[0074] Table 5 PCR standard reaction procedure
[0075]
[0076] (2) Product purification: The PCR product was purified by gel recovery. The gel recovery kit used was purchased from Nanjing Novozyme Biotechnology Co., Ltd., and the product was extracted according to the instructions.
[0077] (3) Plasmid construction:
[0078] The fragment and the vector were connected by Gibson, and the 2×Clon Express Mix used was purchased from Nanjing Novozyme Biotechnology Co., Ltd. The specific reaction system is shown in Table 6. The reaction was carried out at 50°C for 30 minutes.
[0079] Table 6 Gibson reaction system
[0080] Components volume Carrier 20ng / kb Clip 1 20-40ng / kb Clip 2 20-40ng / kb 2 × ClonExpressMix Vector + fragment 1 + fragment 2
[0081] When integrating or knocking out the Saccharomyces cerevisiae genome, it is necessary to construct a plasmid with gRNA (guide RNA). When constructing such a plasmid, Golden Gate is used for assembly. The two enzymes involved are restriction endonuclease BsaI and T4 DNA ligase, which were purchased from Takara. The specific reaction system and reaction procedure are shown in Tables 7 and 8.
[0082] Table 7 Golden Gate reaction system
[0083] Components Volume / Mass Plasmid (pCas-lacz) 100-200ng PCR fragment 20ng / kb BnS 1.6μL T4 enzyme 0.4μL T4Buffer 2μL <![CDATA[H2O]]> up to 20 μL
[0084] Table 8 Golden Gate reaction program
[0085]
[0086] The plasmid in the yeast expression vector pRS414 was assembled by Gibson method.
[0087] During the knockout of the EXG1 gene, the CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) plasmid carrying the gRNA (guide RNA) expression component was constructed using the Golden Gate method. The specific process was as follows: designing a 20bp targeting sequence gRNA sequence, synthesizing primers EXG1-gRNA1-1F and EXG1-gRNA2-2R (Table 3); using plasmid pScURA3 as a template, PCR was performed with primers EXG1-gRNA1-1F and EXG1-gRNA2-2R to obtain the URA fragment with the gRNA scaffold element; gel recovery of the PCR product and Golden Gate assembly with the plasmid pCas-lacz. The gRNA sequences corresponding to the EXG1 gene deletion are AGGGTCTCTTGCAGGGACTG and TCTTACCTAGACCAAGCCAT (5'-3').
[0088] (4) Preparation and transformation of Escherichia coli competent cells:
[0089] First, prepare E. coli Stable competent cells according to the conventional method, and then perform chemical transformation of E. coli competent cells:
[0090] ①Take 50 μL of E. coli competent cells and thaw them on ice. After they are completely dissolved, add Gibson ligation product or Golden Gate ligation product, mix well and place on ice for 30 minutes;
[0091] ② Heat shock for 90 seconds in a 42°C water bath and place on ice for 2 minutes;
[0092] ③ Add 1 mL of LB liquid medium and shake at 37°C and 250 rpm for 30-45 min.
[0093] ④ Centrifuge at 4000 rpm for 3 min, remove the supernatant, apply LBA solid culture medium, and culture in a 37°C incubator.
[0094] (5) Plasmid extraction:
[0095] The plasmid was extracted using an Escherichia coli plasmid extraction kit purchased from Nanjing Novozyme Biotechnology Co., Ltd.
[0096] 1.3 Strain construction
[0097] First, prepare Saccharomyces cerevisiae competent cells according to conventional methods, and then carry out the transformation method of Saccharomyces cerevisiae:
[0098] ① Take 50 μL of Saccharomyces cerevisiae competent medium, add 1 μg of the corresponding plasmid, 5 μL of denatured salmon sperm DNA (denatured at 97°C for 10 min) and 500 μL of 1×PEG / LiAc solution, mix well and place in a 30°C water bath for 30 min;
[0099] ② Add 20 μL DMSO, mix well and place in a 42°C water bath for 15 minutes;
[0100] ③ Centrifuge at 12000rpm for 15s to remove the supernatant;
[0101] ④ Add 800 μL of sterile water, pipette to resuspend the cells, centrifuge, and remove the supernatant;
[0102] ⑤ Add 50 μL of sterile water, pipette to resuspend the bacteria, apply solid culture medium, and culture in a 30°C incubator for 2-3 days.
[0103] EXG1 gene knockout uses the GTR-CRISPR (gRNA-tRNAarray CRISPR) gene editing method. The detailed operation steps are described in reference 2. First, the three expression elements carrying Cas9 protein, gRNA and URA screening markers should be constructed into plasmids according to the Golden gate method. This pCas-sgRNA series plasmid and the donor DNA carrying the corresponding editing site are transferred into the corresponding Saccharomyces cerevisiae competent cells according to the yeast transformation method, and the SC-URA solid culture medium is coated. Among them, the pCas-sgRNA series plasmid is about 500ng, and the donor DNA carrying the corresponding editing site is about 10000ng or more. After culturing in a 30°C incubator for 2-3 days, single clones are picked for PCR verification, and the correct bands are coated with 5-FOA solid culture medium. After culturing at 30°C for 2-3 days, single clones were selected for PCR verification and sent for sequencing confirmation. Single clones with correct sequencing results were simultaneously coated on YPD solid medium and SC-URA solid medium. After culturing at 30°C for three days, single clones grew in YPD medium but not in SC-URA medium, indicating successful knockout or integration.
[0104] 1.4 Glycoside hydrolase in vitro activity test
[0105] Extraction of crude enzyme solution of yeast strain CEN.PK2-1D and Δexg1 and in vitro enzyme activity reaction system:
[0106] (1) Reagent configuration:
[0107] Citric acid buffer: Use 0.2 M Na2HPO4 and 0.1 M citric acid to prepare 50 mM citric acid buffer with a pH of 5.2.
[0108] (2) Preparation of crude enzyme solution:
[0109] ①Inoculate the transformed yeast into a shaking tube containing 3 mL YPD medium / SC- medium, shake overnight at 30°C and 220 rpm, and measure the OD 600nm The value is about 2.0. The seed solution is transferred to 30 mL of the corresponding YPD medium / SC-medium at a ratio of 1:10;
[0110] ② After culturing for 24 hours, collect the cells, incubate at 5000 rpm for 10 minutes at 4°C, discard the supernatant, wash once with pre-cooled citric acid buffer, centrifuge again, and discard the supernatant;
[0111] ③ Add 1 mL / 0.5 mL lysis buffer (50 mM citrate buffer pH = 5.2, 1 mM DTT) to suspend the cells, divide into three 2 mL threaded bacteria-preserving tubes, add 200 μL 0.5 mm glass beads, and break them with a cell homogenizer (break for 30 s, place on ice for 2 min, a total of 10 times);
[0112] ④ Centrifuge at 12000 rpm, 20 min, 4°C, collect the supernatant, and measure the concentration using Nanodrop one at A280 (1Abs = 1 mg / mL).
[0113] (3) Reaction system of glycoside hydrolase:
[0114] Determination of enzyme activity: The enzyme activity reaction system is 100 μL, as shown in Table 9.
[0115] Table 9 Glycoside hydrolase in vitro enzyme activity reaction system
[0116] Reagents Volume (μL) Citrate buffer (pH=5.2, 50 mM, 1 mM DTT added) 100μM substrate (mogroside) 0.5 (stock solution is 10mM) Purified protein (about 20 μg) Total volume 100
[0117] 30℃, react for 24h, terminate the reaction with 3 volumes of methanol, store at -80℃ for 20min, then centrifuge at 12000rpm for 10min. Remove the supernatant, filter and send the sample for LC-MS detection.
[0118] 2 Results and discussion
[0119] In order to understand the growth status of the glycoside hydrolase gene EXG1 knockout strain, the wild strain CEN.PK2-1D and the Δexg1 strain were cultured in 20 mL YPD liquid medium at an initial OD of 600nm The starting OD of the fermentation was 0.1. 600nm , 30°C, 220rpm shaker for fermentation culture, and sampling at different time points. The results showed that the growth rate of the Δexg1 strain was basically consistent with that of the wild strain ( Figure 1 ).
[0120] In order to evaluate the degradation ability of the wild-type strain and the Δexg1 strain on different types of primary and secondary glycosylated mogroside monomers, crude enzyme solutions of the wild-type strain and the Δexg1 strain were extracted and subjected to in vitro enzyme activity analysis, followed by quantitative analysis by triple quadrupole mass spectrometry. The results are shown in Figure 2 , 3 , 4 and 5 as shown.
[0121] Endogenous glycoside hydrolase Exg1 of Saccharomyces cerevisiae can degrade mogroside V to generate mogroside MⅣ-E and simonoside I. Subsequently, under the action of Exg1, both mogroside MⅣ-E and simonoside I are degraded to mogroside IIIE, while mogroside IIIE can be degraded to mogroside IIE, and mogroside IV-A can be degraded to mogroside III, which can then be degraded to mogroside IIE. Exg1 has a stronger degradation ability for mogroside III than for mogroside IIIE, indicating that Exg1 mainly functions to degrade β-1,6-glucosidic bonds, while it also has a weak function to degrade β-1,2-glucosidic bonds (such as Figure 6 However, mogroside ⅡE, mogroside IA and mogroside ⅠE cannot be degraded in Saccharomyces cerevisiae ( Figure 2 ).
[0122] Example 2 Screening and expression of glycosyltransferases
[0123] Mogroside is a glycosylation product synthesized by mogroside alcohol under the catalysis of glycosyltransferase. As shown in its synthesis pathway ( Figure 7 ), from mogroside alcohol to mogroside V, two UDP-glycosyltransferases are involved in the middle. Among them, UGT720-269-1 is responsible for the primary glycosylation of C3 and C24 of mogroside alcohol to produce mogroside IIE; UGT94-289-3 continues to carry out branched chain glycosylation on the basis of mogroside IIE to produce mogroside V. Although it has been predicted that UGT720-269-1 and UGT94-289-3 are involved in the glycosylation sequence of the mogroside biosynthesis pathway in plants, and the feasibility of directly converting mogroside alcohol to mogroside V in vitro or in vivo has been confirmed. However, to date, most natural UDP-glycosyltransferases have low catalytic activity, stability and substrate specificity, and the polysaccharidization process in microorganisms is inefficient and uncontrollable, which makes it difficult to meet the requirements of microbial cell factories, limiting their industrial application. In order to successfully construct the biosynthetic pathway of mogroside in Saccharomyces cerevisiae, the present invention screens and identifies UDP-glycosyltransferases, evaluates the UDP-glycosyltransferases with the best activity and the highest catalytic efficiency, and lays the foundation for achieving the biosynthesis of mogroside from mogroside in Saccharomyces cerevisiae.
[0124] 1 Materials and methods
[0125] 1.1 Strains, plasmids and primers
[0126] The starting strain used in the present invention is the Saccharomyces cerevisiae Δexg1 strain constructed in Example 1, which is used for gene expression, and the constructed yeast strain is shown in Table 10; Escherichia coli (E. colistable) is used for plasmid amplification, and the constructed plasmid is shown in Table 11; the primers used in the plasmid construction process are shown in Table 12. The primers used were synthesized by Beijing Qingke Biotechnology Co., Ltd.
[0127] Table 10 Saccharomyces cerevisiae strains used in the experiments
[0128]
[0129] Table 11 Plasmids used in the experiment
[0130]
[0131] Table 12 Primers used in the experiment
[0132]
[0133]
[0134] 1.2 Plasmid construction
[0135] The construction process of the plasmid used in this embodiment refers to step 1.2 of Example 1. The plasmids on the yeast expression vectors pRS414 and pRS425 were constructed using the Gibson assembly method. The expressed exogenous plant genes UGTMG1, SgUGT720-269-1, UGT430, UGT1576, UGT1697, SgUGT94-289-3, UGTMS1, UGTMS1_M7, UGTMS2, UGT98, and UGT11789 were codon-optimized and synthesized by Beijing Qingke Biotechnology Co., Ltd. UGTMS1_M7 is derived from the mutation of seven bases in the gene UGTMS1, so it can also be directly mutated on the basis of the UGTMS1 gene sequence. The synthesized gene sequence is shown in Table 13.
[0136] In the present invention, the prefix "Sg" of the gene name indicates Momordica grosvenori.
[0137] Table 13 Gene sequences used in the present invention
[0138]
[0139]
[0140]
[0141]
[0142]
[0143] 1.3 Strain construction
[0144] The strain construction process of this example refers to step 1.3 of Example 1.
[0145] 1.4 Glycosyltransferase in vitro activity assay
[0146] (1) Reagents:
[0147] pH = 7.0 Tris·HCl buffer.
[0148] (2) Preparation of crude enzyme solution:
[0149] The preparation steps refer to step 1.4 of Example 1, except that the citric acid buffer is replaced by pH=7.0 Tris·HCl buffer, and the rest are the same as step 1.4 of Example 1.
[0150] (3) Reaction system of glycosyltransferase:
[0151] Determination of enzyme activity: The enzyme activity reaction system is 100 μL, as shown in Table 14.
[0152] Table 14 Glycosyltransferase in vitro enzyme activity reaction system
[0153] Reagents Volume (μL) Tris·HCl (pH=7.0, 50 mM, 2 mM DTT added) 50 100mM Glycosyl Receptor 2 100mM sugar donor (UDP-glucose) 8 Purified protein (about 200 μg / μL) water upto100
[0154] The reaction was carried out at 37°C for 96 hours, and then terminated with 3 volumes of methanol, stored at -80°C for 30 minutes, and then centrifuged at 4°C and 12,000 rpm for 10 minutes. The supernatant was filtered through a 0.22 μM filter membrane and sent for LC-MS detection.
[0155] 1.5 Whole-cell catalysis assay
[0156] (1) Reagent configuration:
[0157] PB buffer: Take 3.1 mL of 0.2 M Na2HPO4, 1.9 mL of 0.2 M NaH2PO4 and 2.5 g of glucose, add water to make up to 50 mL, filter and sterilize with a filter membrane to obtain PB buffer (20 mM, pH = 7.0, 5% glucose).
[0158] (2) Exogenous addition of substrate for yeast in vitro transformation:
[0159] ① Inoculate the transformed yeast monoclone into a shaking tube containing 4 mL YPD medium / SC- medium, and shake overnight at 30°C and 220 rpm;
[0160] ② Transfer the seed solution to a 250 mL conical flask containing 50 mL YPD medium / SC- medium. 600nm Controlled at 0.1-0.2, cultured at 30°C, 250 rpm shaker;
[0161] ③ To enrich the bacteria, after 60 hours of culture, transfer to a 50 mL sterile tube in a clean bench, centrifuge at 500 rpm for 5 minutes, and remove the supernatant;
[0162] ④ Resuspend the cells with sterile water, centrifuge at 500 rpm for 5 minutes, and remove the supernatant;
[0163] ⑤ Resuspend the cells with PB buffer, centrifuge at 500 rpm for 5 minutes, and remove the supernatant;
[0164] ⑥Add 1mL PB buffer to resuspend the cells, dilute 1000 times, and measure OD 600nm ;
[0165] ⑦Total OD of each sample 600nm Keep the final volume consistent and keep it at 1 mL. Then add 5 μL of 10 mM mogrosanol and place it in a 37°C shaker for yeast in vitro transformation.
[0166] (3) Collecting bacteria:
[0167] ① After 24 hours of reaction, add 3 times methanol to stop the reaction, dispense into 4-5 2 mL threaded bacteria-preserving tubes, add 200 μL 0.5 mm glass beads, and break with a cell homogenizer (break for 30 seconds, a total of 10 times);
[0168] ②10min, 12000rpm, centrifuge, collect the supernatant, and enrich the same sample into one tube;
[0169] ③ Rotary evaporation until all liquid evaporates, add 500 μL methanol, and shake;
[0170] ④ After filtering with a 0.22μM filter membrane, send the sample for LC-MS detection.
[0171] 2 Results and discussion
[0172] 2.1 Screening of glycosyltransferases
[0173] Although UGT720-269-1 and UGT94-289-3 can catalyze the production of mogroside V from mogroside alcohol, there is no report on their synthesis of mogroside V in microorganisms after expression in yeast strains. Therefore, it is necessary to modify them to improve their activity, or to screen other UDP-glycosyltransferases that can catalyze the synthesis of mogroside.
[0174] The glycosyltransferases screened by the present invention and their corresponding functions are summarized in Table 15, which are the research objects of the present invention. Among them, UGT74AC1, UGTMG1, UGT720-269-1, UGT430, UGT1576 and UGT1697 are potential enzymes with primary glycosylation of mogroside, and UGT94-289-3, UGTMS1, UGTMS1_M7, UGTMS2, UGT98 and UGT11789 are potential enzymes with secondary glycosylation of mogroside.
[0175] The 23 amino acids at the N-terminus of UGT720-269-1 were deleted to obtain UGT269.1 (-23aa). The reason for the deletion was: based on the relationship between the UGTMS1 and UGT94-289-3 sequences and the existence of catalytic activity, the sequence of UGT720-269-1 was analyzed, and it was found that its N-terminus had similar characteristics to UGT94-289-3, so the 23 amino acids at the N-terminus of UGT720-269-1 were also deleted to evaluate its catalytic ability.
[0176] Table 15 Functions of UGTs
[0177]
[0178] 2.2 Analysis of glycosyltransferase activity
[0179] The 12 glycosyltransferases listed in Table 15 were codon optimized and constructed into corresponding vectors respectively. The gene sequences after codon optimization are shown in Table 13. Among them, the enzymes UGTMG1, UGT720-269-1, UGT720-269-1 (-23aa), UGT430, UGT1576 and UGT1697 responsible for primary glycosylation were constructed into yeast expression vector pRS414; the enzymes UGT94-289-3, UGTMS1, UGTMS1_M7, UGTMS2, UGT98 and UGT11789 responsible for secondary glycosylation were constructed into yeast expression vector pRS425.
[0180] In order to evaluate their activity, the primary glycosylation glycosyltransferases were first transferred into the strain Δexg1, and the crude enzyme solution of the strain was extracted, and UDP-glucose was used as the glycosyl donor and mogroside alcohol was used as the glycosyl acceptor for in vitro enzyme activity analysis, followed by qualitative analysis by triple quadrupole mass spectrometry. The results showed that the crude enzyme extract of strain S-UGTMG1 could catalyze mogroside alcohol to produce mogroside IE and mogroside IIE ( Figure 8 ); The crude enzyme extract of strain S-UGT269.1 can catalyze mogroside to produce mogroside IE ( Fig. 9); the crude enzyme extract of S-UGT269.1(-23aa) can catalyze the conversion of mogroside to mogroside IE and mogroside IIE ( Fig.10 ); The crude enzyme extract of strain S-UGT430 can catalyze the precursor substrate mogroside alcohol to produce mogroside IE and mogroside IIE ( Fig.11 ); The crude enzyme extract of strain S-UGT1576 can catalyze the precursor substrate mogroside to produce mogroside IA ( Fig.12 ); The crude enzyme extract of strain S-UGT1697 can catalyze the precursor substrate mogroside alcohol to produce mogroside IA and trace amounts of mogroside IE and mogroside IIE ( Fig.13 ). Among them, the peak area of mogroside ⅡE produced by strain S-UGTMG1 is the largest, and it is preliminarily determined that the enzyme catalysis ability of UGTMG1 may be the strongest. In the figure, "Mogrol" is mogrol alcohol.
[0181] Based on the above results, the secondary glycosylated glycosyltransferases were transferred into strain S-UGTMG1 to construct strains S-UGT94-289.3, S-UGTMS1, S-UGTMS1_M7, S-UGTMS2, S-UGT98 and S-UGT11789. The crude enzyme solution of the strain was extracted, and the in vitro enzyme activity was analyzed with UDP-glucose as the glycosyl donor and mogrosanol as the glycosyl acceptor, followed by qualitative analysis by triple quadrupole mass spectrometry.
[0182] The results showed that the crude enzyme solution of S-UGT94-289.3 could not detect downstream products; the crude enzyme extract of S-UGTMS1 could catalyze the precursor substrate mogroside alcohol to produce M3 (the isomer of trisaccharide) ( Fig.14 ); The crude enzyme extract of S-UGTMS1_M7 can detect the downstream products M3, mogroside IV-A, mogroside IV-E, mogroside V and the isomers of mogroside V ( Fig.15 ); The crude enzyme extract of S-UGTMS2 can detect the downstream products M3, isomers of mogroside V and simonoside I ( Fig.16 ); The crude enzyme extract of S-UGT98 can detect the downstream products M3, mogroside IV-E, mogroside V and simanoside I ( Fig.17 ); The crude enzyme extract of S-UGT11789 can detect the downstream product mogroside IV-E ( Fig.18 ).
[0183] In summary, the in vitro catalytic ability of the crude enzyme liquid extracted from the screened UDP-glycosyltransferase is shown in Fig.19 .
[0184] 2.3 Whole-cell catalysis for the production of mogroside V
[0185] Whole-cell catalysis is to use the complete multi-enzyme system in the cell to synthesize the corresponding product by cascade reaction of enzymes through substrate addition. Compared with extracting crude enzyme solution of strains for in vitro enzyme catalysis, it can improve the catalytic efficiency, make up for the cascade catalysis and cofactor supply that are difficult to achieve in the crude enzyme solution catalytic reaction, and save the tedious cell disruption process.
[0186] Combined with the expression effect of UDP-glycosyltransferase evaluated in 2.2, UGTMG1, UGT720-269-1 (-23aa), and UGT430 were selected for expression in yeast, and whole-cell catalytic synthesis of mogroside ⅡE was attempted. UGTMS1, UGTMS1_M7, UGTMS2, UGT98, and UGT11789 were expressed in yeast, and whole-cell catalytic synthesis of mogroside V was attempted.
[0187] 2.3.1 Primary glycosylation
[0188] Whole-cell catalysis was performed using strains S-pRS414, S-UGTMG1, S-UGT269.1 (-23aa) and S-UGT430, and mogrosanol was added as a substrate in vitro. Mogrosanol acts as a glycosyl acceptor in the whole-cell catalysis process. Quantitative analysis was then performed using triple quadrupole mass spectrometry. The results are as follows Fig. 20 The mass spectrometry results are shown in Fig.21 , 22 After whole-cell catalysis, a large amount of mogroside ⅠE and mogroside ⅡE were detected in strain S-UGTMG1, and the experimental results were consistent with the in vitro enzyme activity reaction of its crude enzyme extract; after whole-cell catalysis, a small amount of mogroside ⅠE and a trace amount of mogroside ⅡE were detected in strain S-UGT269.1 (-23aa), and its results were consistent with the in vitro enzyme activity experiment of its crude enzyme extract, and its catalytic ability was not as good as S-UGTMG1; while in the whole-cell catalysis experiment of strain S-UGT430, only mogroside ⅠE was detected, and no mogroside ⅡE was detected, which may be due to the fact that the ability of UGT430 to catalyze the production of mogroside ⅡE was too weak and the production of mogroside ⅡE was too low. These results show that UGTMG1 has the strongest catalytic ability and the best catalytic effect among the primary glycosidation isozymes.
[0189] The production of mogroside ⅠE and mogroside ⅡE in strain S-UGTMG1 was 14345.60 ng / mL, and the conversion rates to mogroside alcohol were 44.91% and 8.71%, respectively. UGTMG1 had a strong ability to catalyze the production of mogroside ⅠE using mogroside alcohol as substrate, but had a weak ability to catalyze the production of mogroside ⅡE.
[0190] 2.3.2 Secondary glycosylation
[0191] Combined with the results of primary glycosylation in 2.3.1, strain S-UGTMG1 was used as the starting strain, and plasmids pRS425-MS1, pRS425-MS1_M7, pRS425-MS2, pRS425-98 and pRS425-11789 were respectively transferred to construct strains S-UGTMS1, S-UGTMS1_M7, S-UGTMS2, S-UGT98 and S-UGT11789. Under the same conditions, mogrosanol was selected as the substrate for feeding and whole-cell catalysis was performed. Quantitative analysis was performed by triple quadrupole mass spectrometry, and the results are shown in Fig.23 As shown, the mass spectrometry results are shown in Fig.24 , 25 、26.
[0192] The catalytic system of strain S-UGTMS1 can only detect a small amount of downstream product mogroside III and a very small amount of tetraglycosylated product mogroside IV-A. Compared with other strains, the catalytic system of strain S-UGTMS1_M7 can detect the most types of mogrosides, including a large amount of mogroside III, a small amount of simenoside I and mogroside IV-A, and trace amounts of mogroside IV-E and mogroside V, indicating that UGTMS1_M7 has a strong catalytic ability from mogroside IIE to mogroside III, while the ability is weakened when mogroside III is modified by polysaccharidization, but it can successfully detect simenoside I and mogroside V, the two sweetest mogrosides, which has great research value. Strain S-UGTMS2 performed the worst, and UGTMS2 failed to successfully catalyze downstream glycosides. The strain S-UGT98 successfully detected mogroside III, mogroside IV-A and mogroside V. Although the yield of mogroside III was not as high as that of the strain S-UGTMS1_M7, mogroside IV-A and mogroside V were the highest among all strains. Since the target end product of the present invention is mogroside V, the following research will be continued based on the strain S-UGT98 in subsequent experiments. The strain S-UGT11789 only detected mogroside III in the product of whole-cell catalysis, which was different from the in vitro enzyme activity experiment extracted from its crude enzyme solution, which may be caused by the presence of a multi-enzyme system in the cell during the whole-cell catalytic reaction. The above shows that the present invention has successfully produced mogroside V by means of the whole-cell catalytic method, among which the glycosyltransferase UGT98 has the best catalytic effect on secondary glycosylation and the highest catalytic yield.
[0193] As the strain S-UGT98 with the highest production of mogroside V, the actual production of mogroside III was 1209.22 ng / mL, with a conversion rate of 2.51%, the actual production of mogroside IV-A was 911.61 ng / mL, with a conversion rate of 1.62%, and the actual production of mogroside V was 399.85 ng / mL, with a conversion rate of 0.62%. The conversion rate of the target product mogroside V was extremely low. In order to further increase the production of mogroside V, in addition to increasing the enzyme activity of UDP-glycosyltransferase, the supply of UDP-glucose precursors may also affect the yield of mogroside.
[0194] 2.3.3 Increase UDP-glucose precursor
[0195] Studies have shown that the supply of UDP-glucose precursors in yeast plays a vital role in the biosynthesis of glucosides. Pgm1 is a phosphoglucose invertase that catalyzes the conversion of glucose-1-phosphate to glucose-6-phosphate, which is a key step in hexose metabolism. Ugp1, the full name of which is UDP-glucose pyrophosphorylase, can catalyze the reversible formation of UDP-glucose from 1-phosphate glucose and UTP and participate in a variety of metabolic pathways. The enzymes encoded by the PGM1 and UGP1 genes may be the rate-limiting enzymes involved in regulating the biosynthesis of UDP-glucose. Therefore, high expression of PGM1 and UPG1 is expected to increase the utilization of glucose by chassis cells and increase the content of UDP-glucose in cells. Combined with the results of 2.3.2, the combined expression of glycosyltransferases UGTMG1 and UGT98 has the best effect. It is planned to further increase the yield of whole-cell catalytic production of mogroside V by increasing the UDP-glucose glycosyl donor.
[0196] The invention overexpresses PGM1 and UGP1 genes by constructing plasmids pRS414-PGM1, pRS414-UGP1 and pRS414-PGM1-UGP1; at the same time, two genes UGTMG1 and UGT98 are constructed on the vector pRS425 to obtain plasmid pRS425-98-MG1. Taking Δexg1 as the starting strain, plasmid pRS425-98-MG1 is transferred into Δexg1 strain to obtain strain S1; plasmid pRS425-98-MG1 and pRS414-PGM1 are transferred into Δexg1 strain to obtain strain S2; plasmid pRS425-98-MG1 and pRS414-UGP1 are transferred into Δexg1 strain to obtain strain S3; plasmid pRS425-98-MG1 and pRS414-PGM1-UGP1 are transferred into Δexg1 strain to obtain strain S4. Strain Δexg1 was used as negative control and strains S1, S2, S3, and S4 were subjected to whole-cell catalysis of mogrosanol under the same conditions. The experimental results were quantitatively analyzed by triple quadrupole mass spectrometry. The detection results are shown in Fig. 27 ,28 and 29.
[0197] The results showed that mogroside Ⅲ, mogroside Ⅳ-A and mogroside Ⅴ ( Fig.30 ). The content of mogroside III in strains S2, S3 and S4 was higher than that in strain S1. The production of mogroside IV-A showed a gradual downward trend from strain S1 to S4. The ability of strain S4 to produce mogroside V was slightly stronger than that of strains S2 and S3, but still lower than that of strain S1. The production of mogroside III, mogroside IV-A and mogroside V in strain S1 was detected to be 1149.05 ng / mL, 4097.52 ng / mL and 1842.67 ng / mL, with conversion rates of 2.386%, 7.283% and 2.863%, respectively. The production of mogroside III, mogroside IV-A, mogroside V, and mogroside V in strain S2 was 1516.65 ng / mL, 3557.74 ng / mL, and 883.14 ng / mL, with conversion rates of 3.15%, 6.32%, and 1.37%, respectively. The production of mogroside III, mogroside IV-A, and mogroside V in strain S3 was 1490.40 ng / mL, 3385.42 ng / mL, and 780.11 ng / mL, with conversion rates of 3.10%, 6.02%, and 1.21%, respectively. The production of mogroside III, mogroside IV-A, and mogroside V in strain S4 was 1269.11 ng / mL, 3013.57 ng / mL, and 855.05 ng / mL, with conversion rates of 2.64%, 5.36%, and 1.38%, respectively. The above results indicate that PGM1 and UGP1 did not increase the production of mogroside V by increasing the UDP-glucose donor as expected, and the UDP-glucose donor is not currently the limiting factor in the catalytic synthesis of mogroside V.
[0198] 3 Summary
[0199] The present invention screened UDP-glycosyltransferases and evaluated the screened isozymes to find UGTMG1 with strong primary glycosylation ability and UGT98 with strong secondary glycosylation ability, and successfully synthesized the target product, mogroside V, by means of a whole-cell catalytic method, wherein the yield of mogroside V of the constructed strain S1 reached 1842.67 ng / mL, laying a foundation for the biosynthesis of mogroside from mogrosanol.
[0200] Finally, it should be noted that the above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Although the present invention has been described in detail with reference to the aforementioned embodiments, those skilled in the art can still modify the technical solutions described in the aforementioned embodiments or replace some of the technical features therein by equivalents. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.
Claims
1. An engineered strain of Saccharomyces cerevisiae for producing mogroside, characterized in that: The expression levels of glycosyltransferases UGTMG1 and UGT98 in the exg1 deletion strain of Saccharomyces cerevisiae are increased, or the expression levels of glycosyltransferases UGTMG1 and UGTMS1_M7 in the exg1 deletion strain of Saccharomyces cerevisiae are increased.
2. The engineered yeast of Saccharomyces cerevisiae for producing mogroside according to claim 1, characterized in that: The Saccharomyces cerevisiae exg1 deletion strain is obtained by knocking out the EXG1 gene in Saccharomyces cerevisiae using the gRNA-tRNAarray CRISPR method.
3. The engineered yeast of Saccharomyces cerevisiae for producing mogroside according to claim 1 or 2, characterized in that: The nucleotide sequence of UGTMG1 is SEQ ID No. 1 in the sequence list; and / or The nucleotide sequence of UGT98 is SEQ ID No. 10 in the sequence list; and / or The nucleotide sequence of UGTMS1_M7 is SEQ ID No. 8 in the sequence list.
4. The method for constructing an engineered strain of Saccharomyces cerevisiae for producing mogroside according to any one of claims 1 to 3, characterized in that: The following steps are involved: (1) UGTMG1 was constructed into the yeast expression vector pRS414 to obtain plasmid pRS414-MG1; UGT98 or UGTMS1_M7 was constructed into the yeast expression vector pRS425 to obtain plasmid pRS425-98 or pRS425-MS1_M7; (2) transforming the plasmid pRS414-MG1 obtained in step (1) into the exg1 deletion strain of Saccharomyces cerevisiae to obtain strain S-UGTMG1; (3) The plasmid pRS425-98 or pRS425-MS1_M7 obtained in step (1) is transformed into the strain S-UGTMG1 to obtain the engineered yeast Saccharomyces cerevisiae S-UGT98 or S-UGTMS1_M7 that produces mogroside.
5. The method for constructing an engineered strain of Saccharomyces cerevisiae for producing mogroside according to any one of claims 1 to 3, characterized in that: The following steps are involved: (1) Both UGTMG1 and UGT98 genes were constructed into the vector pRS425 to obtain plasmid pRS425-98-MG1; (2) The plasmid pRS425-98-MG1 was transformed into the exg1 deletion strain of Saccharomyces cerevisiae to obtain the engineered strain S1 of Saccharomyces cerevisiae that produces mogroside.
6. Use of the engineered yeast Saccharomyces cerevisiae according to any one of claims 1 to 3 in producing mogroside.
7. The use according to claim 6, characterized in that: The mogroside includes at least one of mogroside III, simanoside I, mogroside IV-A, mogroside IV-E and mogroside V; preferably, the mogroside is mogroside V.
8. The use according to claim 6 or 7, characterized in that: Cultivate the engineered yeast of any one of claims 1 to 3, add mogrosanthes alcohol to carry out in vitro transformation of the yeast, and after the transformation is completed, add methanol to stop the reaction.
9. A method for producing mogroside, characterized in that: Cultivate the engineered yeast of any one of claims 1 to 3, add mogrosanthes alcohol to carry out in vitro transformation of the yeast, and after the transformation is completed, add methanol to stop the reaction.
10. The method according to claim 9, characterized in that: The mogroside includes at least one of mogroside III, simanoside I, mogroside IV-A, mogroside IV-E and mogroside V; preferably, the mogroside is mogroside V.
Citation Information
Patent Citations
Methods and materials for biosynthesis of mogroside compounds
CN107466320A
Methods for making high intensity sweeteners
CN111108213A
Methods for making high intensity sweeteners
CN113316394A
Method for biosynthesizing high-sweetness mogroside V by using siamenoside
CN118109545A
